Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 260,211 shares at $16.11 ($4.2M) on 2025-11-17, disclosed to the SEC on 2025-11-17.
Scheduled sale ($4.2M) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.00 | 1,111 | $18K | 0.4% |
| 2 | $16.02 | 110,228 | $1.8M | 42.3% |
| 3 | $16.02 | 110,228 | $1.8M | 42.3% |
| 4 | $16.11 | 18,572 | $299K | 7.2% |
| 5 | $16.11 | 18,572 | $299K | 7.2% |
| 6 | $17.07 | 1,500 |
| $26K |
| 0.6% |
| Total | $16.04 avg | 260,211 | $4.2M | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2024-06-10 | $74K | — | Filing → |